Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates
Incannex Healthcare Inc. (NASDAQ: IXHL) recently disclosed its fiscal second-quarter 2025 financial results and provided updates regarding its business operations. The company, based in Melbourne, Australia, is a clinical-stage biopharmaceutical firm at the forefront of developing oral combination medicines aiming to address various medical conditions. Joel Latham, the President and Chief Executive Officer of Incannex, […]
Incannex Healthcare Inc. (NASDAQ: IXHL) recently disclosed its fiscal second-quarter 2025 financial results and provided updates regarding its business operations. The company, based in Melbourne, Australia, is a clinical-stage biopharmaceutical firm at the forefront of developing oral combination medicines aiming to address various medical conditions. Joel Latham, the President and Chief Executive Officer of Incannex, […]
